Twitter Facebook LinkedIn YouTube

Deer Horn Capital has increased the size of its recently announced non-brokered private placement

Video Platform Video Management Video Solutions Video Player

The company is looking to raise gross proceeds of up to $400,000 from the placement of up to 4 million units priced at $0.10 per unit. The units consist of 1 share and 1 warrant, with each warrant exercisable at $0.15 for 24 months.

Additional Information:

Company: Deer Horn Capital
Website: http://www.deerhorncapital.ca
Stock Symbol: CSE: DHC
Date Published: Sep 8, 2020
Transcript: Available

Video Transcript:

I’m Cassandra Bolinski for Investmentpitch Media

Deer Horn Capital has increased the size of its recently announce non-brokered private placement.

The company is looking to raise gross proceeds of up to $400,000 from the placement of up to 4 million units priced at $0.10 per unit.

The units consist of 1 share and 1 warrant, with each warrant exercisable at $0.15 for 24 months.

The shares are currently trading at $0.09.

Proceeds will be used for general corporate purposes.

Deer Horn’s subsidiary, Cheona Health signed an MOU on August 6th with Impact@RESOLVE, LLC and Tokimus Biotech to help distribute Covid-19 test kits from South Korea into the United States.

Distribution will be initially targeted to disadvantaged communities that are particularly vulnerable to Covid-19.

Cheona Health, in which Deer Horn holds a 49% interest, is led by Indigenous leader Allen Edzerza and was formed to help Indigenous communities achieve better health and well-being.

Focused on reducing the spread of Covid-19 in Canada and facilitate convenient and effective testing for the disease, Cheona Health’s first step in this mission is to supply safe, fast and affordable FDA-approved Covid-19 test kits to Tribal communities.

Stephen D’Esposito, President and CEO of RESOLVE, stated: “When a crisis like Covid-19 hits, we mobilize our networks. This agreement with Tokimus and Cheona Health aligns perfectly with our mandate to rapidly develop, test, deploy, and scale creative solutions to help tackle urgent problems like critical resource shortages.”

Tokimus Biotech, founded by a group of medical practitioners and importers dedicated to providing fairly-priced, quality disease testing kits and other medical products in North America, is registered with the US FDA as a direct medical importer.

Patrick Riggs, President and CEO of Tokimus, added: “From the beginning, we’ve focused our medical supply chain on South Korea. We have developed exclusive supply agreements with some of South Korea’s leading medical device manufacturers. Their pricing is fair, and their quality and standards are rigorous and exceptional.”

Tyrone Docherty, President and CEO, stated: “The combined power of IMPACT, RESOLVE, Tokimus and Cheona Health will be formidable in the fight against Covid-19. “Not only are we harnessing the power and reach of an NGO like RESOLVE that was able to quickly scale a PPE response to Covid-19 with companies like Cisco and Coca-Cola and governors in the US, we’re working with Allen Edzerza, one of Canada’s most respected Indigenous leaders. Add to this Tokimus’ network of diversified medical device companies in South Korea, and you have a perfect combination to get crucial, high-quality Covid-19 testing into disadvantaged communities that need it urgently.”

Deer Horn is also applying for a five-year exploration permit as part of its permit application for a 10,000-tonne bulk sample at the company’s 51.3-square-kilometer, Deer Horn gold-silver-tellurium property located 135 kilometres southwest of the community of Burns Lake and 36 kilometres south of the Huckleberry mine in west-central British Columbia.

The permit will be used for drilling and other exploration to expand the property’s current NI 43-101 resource of high-grade gold, silver and tellurium.

The company has produced positive economics in a Preliminary Economic Analysis and, to management’s knowledge, hosts Canada’s only NI 43‐101 tellurium resource.
For more information, please visit the company’s website at www.deerhorncapital.ca, contact Tyrone Docherty, President and CEO, at 604-789-5653 or email tyrone@deerhorncapital.ca.

I’m Cassandra Bolinski for Investmentpitch Media